Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
20 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
ASAC Pharmaceutical International Articles
Asac Eyes USA
25 July 1994
Showing 1-1 of 1 articles
1
Hot Topics
Most Read
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
Bristol-Myers' data on Yervoy and nivolumab causes a stir
New study shows UCB's Neupro reduces NSBP in RLS patient
Encouraging results with Sangamo's SB-728-T in HIV treatment
Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
Bristol-Myers' data on Yervoy and nivolumab causes a stir
New study shows UCB's Neupro reduces NSBP in RLS patient
Encouraging results with Sangamo's SB-728-T in HIV treatment
Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results